171 related articles for article (PubMed ID: 36739402)
1. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract][Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract][Full Text] [Related]
3. Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.
Mao L; Dai J; Cao Y; Bai X; Sheng X; Chi Z; Cui C; Kong Y; Zhang Y; Wu L; Wang X; Tang B; Lian B; Yan X; Li S; Zhou L; Wei X; Li C; Qi Z; Si L; Guo J
Eur J Cancer; 2021 May; 148():297-306. PubMed ID: 33770575
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in primary melanoma in Taiwan.
Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
[TBL] [Abstract][Full Text] [Related]
5. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
Kong Y; Sheng X; Wu X; Yan J; Ma M; Yu J; Si L; Chi Z; Cui C; Dai J; Li Y; Yu H; Xu T; Tang H; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Guo J
Clin Cancer Res; 2017 Nov; 23(22):6946-6957. PubMed ID: 28830923
[No Abstract] [Full Text] [Related]
6. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
Elefanti L; Zamuner C; Del Fiore P; Stagni C; Pellegrini S; Dall'Olmo L; Fabozzi A; Senetta R; Ribero S; Salmaso R; Mocellin S; Bassetto F; Cavallin F; Tosi AL; Galuppini F; Dei Tos AP; Menin C; Cappellesso R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917086
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CCNE1 copy number gain in acral melanoma patients.
Wu X; Yan J; Yu J; Cheng Z; Guo Q; Kong Y; Guo J
Melanoma Res; 2021 Aug; 31(4):352-357. PubMed ID: 33965974
[TBL] [Abstract][Full Text] [Related]
8.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
[TBL] [Abstract][Full Text] [Related]
11. Genomic Landscapes of Acral Melanomas in East Asia.
Chang JW; Hsieh JJ; Wu CE; Lim AH; Ng CC; Teh BT; Chan JY
Cancer Genomics Proteomics; 2021; 18(1):83-92. PubMed ID: 33419898
[TBL] [Abstract][Full Text] [Related]
12. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
14. Advanced Acral Melanoma Therapies: Current Status and Future Directions.
Zhang Y; Lan S; Wu D
Curr Treat Options Oncol; 2022 Oct; 23(10):1405-1427. PubMed ID: 36125617
[TBL] [Abstract][Full Text] [Related]
15. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.
Sun W; Xu Y; Qu X; Jin Y; Wang C; Yan W; Chen Y
Arch Dermatol Res; 2023 Oct; 315(8):2305-2312. PubMed ID: 36988664
[TBL] [Abstract][Full Text] [Related]
18. Mutational profiling of acral melanomas in Korean populations.
Shim JH; Shin HT; Park J; Park JH; Lee JH; Yang JM; Kim DH; Jang KT; Lee DY
Exp Dermatol; 2017 Oct; 26(10):883-888. PubMed ID: 28191690
[TBL] [Abstract][Full Text] [Related]
19. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A
Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
Wei X; Chen Y; Yao H; Wu D; Li H; Zhang R; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Gershenwald JE; Balch CM; Guo J; Si L
J Am Acad Dermatol; 2022 Dec; 87(6):1287-1294. PubMed ID: 36075285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
